- Previous Close
88.40 - Open
88.40 - Bid 85.00 x --
- Ask 88.40 x --
- Day's Range
86.00 - 88.40 - 52 Week Range
73.00 - 112.50 - Volume
17 - Avg. Volume
180 - Market Cap (intraday)
124.615M - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-1.99 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland.
www.urteste.comRecent News: URT.WA
View MorePerformance Overview: URT.WA
Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: URT.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: URT.WA
View MoreValuation Measures
Market Cap
124.61M
Enterprise Value
109.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.89
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-11.14%
Return on Equity (ttm)
-15.27%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.28M
Diluted EPS (ttm)
-1.99
Balance Sheet and Cash Flow
Total Cash (mrq)
18.98M
Total Debt/Equity (mrq)
2.67%
Levered Free Cash Flow (ttm)
-10.71M